Selected research
Industry Research
Bromhexine Hydrochloride Injection Industry Research Report 2026
Market perspective
The global Bromhexine Hydrochloride Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bromhexine Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bromhexine Hydrochloride Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bromhexine Hydrochloride Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bromhexine Hydrochloride Injection include Jiangxi Yiyou Pharmaceutical, Guangzhou Yipinhong Pharmaceutical, Shanghai Xudong Haipu Pharmaceutical, Chengdu Giantech Hi-Technology, Shijiazhuang No.4 Pharmaceutical, Shandong Shenglu, Jiangzhong Pharmaceutical, Hebei Renhe Yikang Pharmaceutical and Hainan Huluwa Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bromhexine Hydrochloride Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bromhexine Hydrochloride Injection Market by Company
Jiangxi Yiyou Pharmaceutical
Guangzhou Yipinhong Pharmaceutical
Shanghai Xudong Haipu Pharmaceutical
Chengdu Giantech Hi-Technology
Shijiazhuang No.4 Pharmaceutical
Shandong Shenglu
Jiangzhong Pharmaceutical
Hebei Renhe Yikang Pharmaceutical
Hainan Huluwa Pharmaceutical
PT Meprofarm
Brix Biopharma
Bromhexine Hydrochloride Injection Segment by Type
Injection
Powder Injection
Bromhexine Hydrochloride Injection Segment by Application
Clinic
Hospital
Others
Bromhexine Hydrochloride Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bromhexine Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bromhexine Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bromhexine Hydrochloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bromhexine Hydrochloride Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bromhexine Hydrochloride Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bromhexine Hydrochloride Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Powder Injection
Applications
- Clinic
- Hospital
- Others
Companies covered
- Jiangxi Yiyou Pharmaceutical
- Guangzhou Yipinhong Pharmaceutical
- Shanghai Xudong Haipu Pharmaceutical
- Chengdu Giantech Hi-Technology
- Shijiazhuang No.4 Pharmaceutical
- Shandong Shenglu
- Jiangzhong Pharmaceutical
- Hebei Renhe Yikang Pharmaceutical
- Hainan Huluwa Pharmaceutical
- PT Meprofarm
- Brix Biopharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bromhexine Hydrochloride Injection Market Size (2021-2032)
- 2.2.2 Global Bromhexine Hydrochloride Injection Sales (2021-2032)
- 2.2.3 Global Bromhexine Hydrochloride Injection Market Average Price (2021-2032)
- 2.3 Bromhexine Hydrochloride Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Injection
- 2.3.3 Powder Injection
- 2.4 Bromhexine Hydrochloride Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Clinic
- 2.4.3 Hospital
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bromhexine Hydrochloride Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bromhexine Hydrochloride Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Bromhexine Hydrochloride Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Bromhexine Hydrochloride Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Bromhexine Hydrochloride Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bromhexine Hydrochloride Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bromhexine Hydrochloride Injection, Product Type & Application
- 3.8 Global Manufacturers of Bromhexine Hydrochloride Injection, Established Date
- 3.9 Global Bromhexine Hydrochloride Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Jiangxi Yiyou Pharmaceutical
- 4.1.1 Jiangxi Yiyou Pharmaceutical Company Information
- 4.1.2 Jiangxi Yiyou Pharmaceutical Business Overview
- 4.1.3 Jiangxi Yiyou Pharmaceutical Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Jiangxi Yiyou Pharmaceutical Bromhexine Hydrochloride Injection Product Portfolio
- 4.1.5 Jiangxi Yiyou Pharmaceutical Recent Developments
- 4.2 Guangzhou Yipinhong Pharmaceutical
- 4.2.1 Guangzhou Yipinhong Pharmaceutical Company Information
- 4.2.2 Guangzhou Yipinhong Pharmaceutical Business Overview
- 4.2.3 Guangzhou Yipinhong Pharmaceutical Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Guangzhou Yipinhong Pharmaceutical Bromhexine Hydrochloride Injection Product Portfolio
- 4.2.5 Guangzhou Yipinhong Pharmaceutical Recent Developments
- 4.3 Shanghai Xudong Haipu Pharmaceutical
- 4.3.1 Shanghai Xudong Haipu Pharmaceutical Company Information
- 4.3.2 Shanghai Xudong Haipu Pharmaceutical Business Overview
- 4.3.3 Shanghai Xudong Haipu Pharmaceutical Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shanghai Xudong Haipu Pharmaceutical Bromhexine Hydrochloride Injection Product Portfolio
- 4.3.5 Shanghai Xudong Haipu Pharmaceutical Recent Developments
- 4.4 Chengdu Giantech Hi-Technology
- 4.4.1 Chengdu Giantech Hi-Technology Company Information
- 4.4.2 Chengdu Giantech Hi-Technology Business Overview
- 4.4.3 Chengdu Giantech Hi-Technology Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Chengdu Giantech Hi-Technology Bromhexine Hydrochloride Injection Product Portfolio
- 4.4.5 Chengdu Giantech Hi-Technology Recent Developments
- 4.5 Shijiazhuang No.4 Pharmaceutical
- 4.5.1 Shijiazhuang No.4 Pharmaceutical Company Information
- 4.5.2 Shijiazhuang No.4 Pharmaceutical Business Overview
- 4.5.3 Shijiazhuang No.4 Pharmaceutical Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shijiazhuang No.4 Pharmaceutical Bromhexine Hydrochloride Injection Product Portfolio
- 4.5.5 Shijiazhuang No.4 Pharmaceutical Recent Developments
- 4.6 Shandong Shenglu
- 4.6.1 Shandong Shenglu Company Information
- 4.6.2 Shandong Shenglu Business Overview
- 4.6.3 Shandong Shenglu Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Shandong Shenglu Bromhexine Hydrochloride Injection Product Portfolio
- 4.6.5 Shandong Shenglu Recent Developments
- 4.7 Jiangzhong Pharmaceutical
- 4.7.1 Jiangzhong Pharmaceutical Company Information
- 4.7.2 Jiangzhong Pharmaceutical Business Overview
- 4.7.3 Jiangzhong Pharmaceutical Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jiangzhong Pharmaceutical Bromhexine Hydrochloride Injection Product Portfolio
- 4.7.5 Jiangzhong Pharmaceutical Recent Developments
- 4.8 Hebei Renhe Yikang Pharmaceutical
- 4.8.1 Hebei Renhe Yikang Pharmaceutical Company Information
- 4.8.2 Hebei Renhe Yikang Pharmaceutical Business Overview
- 4.8.3 Hebei Renhe Yikang Pharmaceutical Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Hebei Renhe Yikang Pharmaceutical Bromhexine Hydrochloride Injection Product Portfolio
- 4.8.5 Hebei Renhe Yikang Pharmaceutical Recent Developments
- 4.9 Hainan Huluwa Pharmaceutical
- 4.9.1 Hainan Huluwa Pharmaceutical Company Information
- 4.9.2 Hainan Huluwa Pharmaceutical Business Overview
- 4.9.3 Hainan Huluwa Pharmaceutical Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Hainan Huluwa Pharmaceutical Bromhexine Hydrochloride Injection Product Portfolio
- 4.9.5 Hainan Huluwa Pharmaceutical Recent Developments
- 4.10 PT Meprofarm
- 4.10.1 PT Meprofarm Company Information
- 4.10.2 PT Meprofarm Business Overview
- 4.10.3 PT Meprofarm Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 PT Meprofarm Bromhexine Hydrochloride Injection Product Portfolio
- 4.10.5 PT Meprofarm Recent Developments
- 4.11 Brix Biopharma
- 4.11.1 Brix Biopharma Company Information
- 4.11.2 Brix Biopharma Business Overview
- 4.11.3 Brix Biopharma Bromhexine Hydrochloride Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Brix Biopharma Bromhexine Hydrochloride Injection Product Portfolio
- 4.11.5 Brix Biopharma Recent Developments
5 Global Bromhexine Hydrochloride Injection Market Scenario by Region
- 5.1 Global Bromhexine Hydrochloride Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bromhexine Hydrochloride Injection Sales by Region: 2021-2032
- 5.2.1 Global Bromhexine Hydrochloride Injection Sales by Region: 2021-2026
- 5.2.2 Global Bromhexine Hydrochloride Injection Sales by Region: 2027-2032
- 5.3 Global Bromhexine Hydrochloride Injection Revenue by Region: 2021-2032
- 5.3.1 Global Bromhexine Hydrochloride Injection Revenue by Region: 2021-2026
- 5.3.2 Global Bromhexine Hydrochloride Injection Revenue by Region: 2027-2032
- 5.4 North America Bromhexine Hydrochloride Injection Market Facts & Figures by Country
- 5.4.1 North America Bromhexine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bromhexine Hydrochloride Injection Sales by Country (2021-2032)
- 5.4.3 North America Bromhexine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bromhexine Hydrochloride Injection Market Facts & Figures by Country
- 5.5.1 Europe Bromhexine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bromhexine Hydrochloride Injection Sales by Country (2021-2032)
- 5.5.3 Europe Bromhexine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bromhexine Hydrochloride Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bromhexine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bromhexine Hydrochloride Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bromhexine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bromhexine Hydrochloride Injection Market Facts & Figures by Country
- 5.7.1 South America Bromhexine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bromhexine Hydrochloride Injection Sales by Country (2021-2032)
- 5.7.3 South America Bromhexine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bromhexine Hydrochloride Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bromhexine Hydrochloride Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bromhexine Hydrochloride Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bromhexine Hydrochloride Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bromhexine Hydrochloride Injection Sales by Type (2021-2032)
- 6.1.1 Global Bromhexine Hydrochloride Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Bromhexine Hydrochloride Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Bromhexine Hydrochloride Injection Revenue by Type (2021-2032)
- 6.2.1 Global Bromhexine Hydrochloride Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bromhexine Hydrochloride Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Bromhexine Hydrochloride Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bromhexine Hydrochloride Injection Sales by Application (2021-2032)
- 7.1.1 Global Bromhexine Hydrochloride Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Bromhexine Hydrochloride Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Bromhexine Hydrochloride Injection Revenue by Application (2021-2032)
- 7.2.1 Global Bromhexine Hydrochloride Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bromhexine Hydrochloride Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Bromhexine Hydrochloride Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bromhexine Hydrochloride Injection Value Chain Analysis
- 8.1.1 Bromhexine Hydrochloride Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bromhexine Hydrochloride Injection Production Mode & Process
- 8.2 Bromhexine Hydrochloride Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bromhexine Hydrochloride Injection Distributors
- 8.2.3 Bromhexine Hydrochloride Injection Customers
9 Global Bromhexine Hydrochloride Injection Analyzing Market Dynamics
- 9.1 Bromhexine Hydrochloride Injection Industry Trends
- 9.2 Bromhexine Hydrochloride Injection Industry Drivers
- 9.3 Bromhexine Hydrochloride Injection Industry Opportunities and Challenges
- 9.4 Bromhexine Hydrochloride Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst